Futura Medtech

What Futura Medtech does

Futura Medtech is a Bengaluru-headquartered medical devices manufacturer and PE-backed platform company operating across surgical sutures, meshes, wound closure products, and implants for orthopaedics, neurosurgery, and interventional cardiology. The company manufactures in-house and distributes through a network of more than 100 channel partners across India and 85+ international markets. Founded in 1994 by A D Setty, who continues as Founder and Chairman, Futura Medtech has historically been anchored in surgical sutures and wound closure consumables.

Since 2024 the company has operated as a multi-category medical devices platform under private equity sponsor Jashvik Capital, which committed $25 million in 2024 to finance a roll-up strategy. The platform has executed three strategic acquisitions: Dolphin Sutures (October 2024) and Suture Planet (July 2025) in surgical sutures, and Rivarp Medical (April 2026) in orthopaedic, neurosurgical, and interventional cardiology devices. Rivarp Medical brings EU MDR and US FDA regulatory certifications that materially extend Futura's ability to serve regulated international markets.

Futura generates revenue through direct hardware sales of medical devices, implants, sutures, meshes, and bone wax to healthcare providers, surgical centres, catheterisation labs, and hospital procurement channels. The platform combines retained acquired brands, shared distribution infrastructure, and certified manufacturing to pursue scale advantages over single-category Indian competitors, with Jashvik Capital having signalled additional capital deployment over the subsequent two-year horizon.

Name

Futura Medtech

Website

https://futuramedtech.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

Futura Medtech is a Bengaluru-based PE-backed medical devices platform manufacturing surgical sutures, meshes, wound closure products, and implants for orthopaedics, neurosurgery, and interventional cardiology, distributed across India and 85+ international markets.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Medical & Healthcare Hygiene Disposables (Patient Wipes, Underpads) (IMAMAGAF)

akta.pro secondary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Surgical sutures
• Wound closure products
• Orthopaedic implants
• Neurosurgical devices
• Interventional cardiology devices

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Devices and Implants Sales: Futura Medtech generates revenue through the sale of medical devices and implants manufactured by its platform companies, including orthopaedic implants, neurosurgical devices, interventional cardiology products, sutures, and bone wax, distributed across India and 85+ international markets.

Go-to-market motion2 records

Distribution channels1 record

Core offering

Futura Medtech is a Bengaluru-based medical device platform that manufactures and supplies surgical sutures, surgical meshes, and wound closure products, with product lines spanning orthopaedics, neurosurgery, and interventional cardiology. The company operates as a multi-brand platform consolidated through three acquired businesses (Dolphin Sutures, Suture Planet, and Rivarp Medical) and distributes its products through 100+ channel partners across India and 85+ international markets.

Product overview

Futura Medtech operates as a multi-category medical devices platform under Jashvik Capital's portfolio. The platform aggregates acquired medical device brands including Dolphin Sutures (October 2024), Suture Planet (July 2025), and Rivarp Medical (April 2026), combining their manufacturing capabilities with Futura's distribution network across India and 85+ international markets through over 100 channel partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Dolphin Sutures
• Suture Planet
• Rivarp Medical
• Surgical Meshes

Quantifiable outcome

• Distribution across India and 85+ international markets

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• Rivarp MedicalcoreStrategic or Co-development Partner · 28 April 2026Futura Medtech made a strategic investment in Bengaluru-based Rivarp Medical, a manufacturer of medical devices and implants spanning orthopaedics, neurosurgery, and interventional cardiology. Founded in 2016, Rivarp Medical operates with in-house manufacturing and holds EU MDR and US FDA certifications. This is the third investment under the Futura Medtech platform, following Dolphin Sutures (October 2024) and Suture Planet (July 2025). The investment aims to accelerate growth and portfolio innovation by combining Rivarp's manufacturing capabilities with Futura's distribution network across India and 85+ international markets.
• Suture PlanetcoreStrategic or Co-development Partner · 1 July 2025Suture Planet was the second investment under the Futura Medtech platform (July 2025), further expanding the platform's suture and wound closure product offerings alongside Dolphin Sutures.
• Dolphin SuturescoreStrategic or Co-development Partner · 1 October 2024Dolphin Sutures was the first investment under the Futura Medtech platform (October 2024), expanding Futura's portfolio into surgical sutures and wound closure products with in-house manufacturing capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ethicon (Johnson & Johnson MedTech): World's largest sutures and wound closure franchise, part of J&J MedTech. Directly competes with Dolphin Sutures and Suture Planet globally with significantly larger R&D and brand investment.
• Smith & Nephew: Global medical device company with established orthopaedics, sports medicine, and advanced wound management franchises. Overlaps with Futura's orthopaedic implant and wound closure categories.
• Medtronic: Global leader in interventional cardiology and neurosurgery devices. Direct competitor to Rivarp Medical's interventional cardiology and neurosurgery implant portfolio at the premium hospital tier.
• Stryker: Global orthopaedic and medical device leader. Direct competitor to Futura's orthopaedic implant offering via Rivarp Medical, with deeper surgeon relationships and broader product pipeline.
• B. Braun: Global medical device and pharmaceutical company with a large sutures, wound closure, and surgical instruments franchise. Overlaps with Futura's Dolphin/Suture Planet in sutures and with Rivarp in surgical instruments.

Direct peers

• Poly Medicure: Indian medical device manufacturer of consumables and devices across infusion therapy, sutures, and surgical specialties. Comparable multi-category manufacturing platform serving hospital customers domestically and internationally.
• Healthium Medtech: India-based medical device company specialising in surgical sutures, wound closure, and arthroscopy/orthopaedic consumables. Direct domestic competitor with overlapping suture and consumables portfolio and similar India-plus-exports distribution model.
• Sutures India: Indian manufacturer of surgical sutures and wound care products. Closest suture-only competitor to Futura's Dolphin Sutures and Suture Planet subsidiaries with comparable hospital customer base.
• Conmed: US-listed medical device company focused on general surgery (sutures, mesh), orthopaedics, and sports medicine. Direct cross-specialty competitor to Futura's suture and orthopaedic implant portfolio.
• Meril Life Sciences: India-headquartered medical device company with portfolio spanning orthopaedic implants, cardiovascular devices, and surgical consumables. Closest Indian multi-specialty platform competitor with overlapping ortho and cardiology exposure.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Futura Medtech